Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational studyObservational Study Published on 2023-02-012023-07-11 Journal: Journal of infection and public health [Category] COVID19(2023년), [키워드] Comorbidity COVID-19 omicron SARS-CoV-2 viral shedding time. [DOI] 10.1016/j.jiph.2022.12.003 PMC 바로가기 [Article Type] Observational Study
Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and EuropeArticle Published on 2023-01-012023-07-07 Journal: The Journal of asthma : official journal of the Association for the Care of [Category] COVID19(2023년), [키워드] Asthma Comorbidity COVID-19 epidemiology. [DOI] 10.1080/02770903.2021.2025392 PMC 바로가기
Risk and protective factors for new-onset binge eating, low weight, and self-harm symptoms in >35,000 individuals in the UK during the COVID-19 pandemicArticle Published on 2023-01-012023-07-10 Journal: The International journal of eating disorders [Category] COVID19(2023년), [키워드] Comorbidity eating disorders mental health Psychiatric disorders suicidal ideation. [DOI] 10.1002/eat.23834 PMC 바로가기
Survival analysis and mortality predictors of COVID-19 in a pediatric cohort in MexicoArticle Published on 2022-12-162023-07-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), [키워드] Comorbidity COVID-19 Mexico Mortality pediatrics. SARS-CoV-2 [DOI] 10.3389/fpubh.2022.969251 PMC 바로가기
Identification of CKD, bedridden history and cancer as higher-risk comorbidities and their impact on prognosis of hospitalized Omicron patients: a multi-centre cohort studyArticle Published on 2022-12-012022-11-16 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 치료기술, [키워드] advanced age age Cancer China Chronic kidney disease CKD cohort study Comorbidity condition conditions COVID-19 critical cases enrolled Factor female first positive hospialized population Hospitalized hospitalized patient hypertension identification Logistic regression Metabolic disorders multivariate Observational cohort study omicron participant Patient patients Primary outcome Prognosis progression risk factor Risk factors Risk factors. SARS-CoV-2 SARS-CoV-2 detection secondary outcome severity Shanghai suggested vaccination viral shedding [DOI] 10.1080/22221751.2022.2122581 PMC 바로가기
Clinical manifestations of COVID-19 in patients with asthma, hypertension, and diabetes mellitusArticle Published on 2022-12-012023-07-11 Journal: Journal of Medicine and Life [Category] COVID19(2023년), [키워드] Asthma Comorbidity COVID-19 DM hypertension. [DOI] 10.25122/jml-2021-0364 PMC 바로가기
Signs and symptoms of COVID-19 in patients with multiple sclerosisArticle Published on 2022-12-012022-11-16 Journal: European journal of neurology [Category] COVID19(2023년), SARS, 변종, [키워드] affected Ageusia alcohol Analysis Anosmia anti-CD20 therapy association chest pain clinical collected Comorbidity coronavirus disease COVID-19 COVID-19 symptom COVID-19 symptoms Delta Demyelinating diseases difference disease-modifying treatment Factor flu-like symptom Frequency greater identify Infection investigated joint less Linear regression model multiple sclerosis Neurological disorders neurological disorders. number of symptom Occurrence Odds ratio Older outcome Pain Patient Rash recognize risk factor Shortness of breath SIGN similarity smoke smoker Symptom symptoms of COVID-19 Tachycardia therapeutic approach therapy variant [DOI] 10.1111/ene.15554 PMC 바로가기
Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot studySARS-COV-2 감염 및 급성 신장 손상 마커에 의해 유도 된 변경된 신장 기능 COVID-19 환자의 생존 결과를 예측합니다 : 전향 적 파일럿 연구Article Published on 2022-12-012022-08-31 Journal: Renal failure [Category] COVID19(2023년), SARS, 바이오마커, [키워드] acute kidney Acute kidney injury adjusted Advancing age Altered Analysis association Biomarker chronic Chronic kidney disease collaboration Comorbidities Comorbidity Control coronavirus disease Coronavirus disease 2019 covariate covariates COVID-19 COVID-19 patient COVID-19 patients creatinine Cumulative rates cystatin C death demonstrated elevated examined group groups Hospitalized ICU intensive care intensive care unit investigated Kaplan-Meier method kidney kidney damage Kidney disease Kidney function Kidney function tests Kidney injury literature marker morbidity multivariable Cox regression outcome participant pilot study predict Predictive Predictive value Proteinuria retained risk factor Risk factors SARS-COV-2 infection serum serum creatinine Sex significant difference statistically subject survival survival analysis survival analysis. the Kaplan-Meier method Treatment Urine with COVID-19 [DOI] 10.1080/0886022X.2022.2032743 PMC 바로가기 [Article Type] Article
COVID-19 Inpatient Mortality Disparities Among American Indian Adults in Mississippi’s Safety Net HospitalArticle Published on 2022-12-012023-07-06 Journal: Journal of racial and ethnic health disparities [Category] COVID19(2023년), [키워드] American Indian Comorbidity COVID-19 Health disparities Inpatient mortality Mississippi. [DOI] 10.1007/s40615-021-01152-y PMC 바로가기
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatientsArticle Published on 2022-11-072022-11-16 Journal: BMC Infectious Diseases [Category] SARS, 변종, [키워드] 95% CI 95% confidence interval adjusted odds ratio Administered age Characteristics clinical trial Comorbidity COVID-19 COVID-19 outpatient death defined died early symptomatic COVID-19 effective Electronic health record health system Hospitalization Hospitalized immunocompromised status lack mAb mAbs Male sex Mild monoclonal antibodies monoclonal antibody monoclonal antibody treatment Mortality mortality data multicenter Neutralizing obesity Observational cohort study occurred pandemic Patient patients patients with COVID-19 positive Primary outcome real-world data reducing SARS-CoV-2 SARS-CoV-2 test SARS-CoV-2 vaccination SARS-CoV-2. Treatment Vaccine variants while [DOI] 10.1186/s12879-022-07819-z PMC 바로가기